Literature DB >> 1596846

Canadian heart health surveys: a profile of cardiovascular risk. Survey methods and data analysis. Canadian Heart Health Surveys Research Group.

D R MacLean1, A Petrasovits, M Nargundkar, P W Connelly, E MacLeod, A Edwards, P Hessel.   

Abstract

OBJECTIVE: To describe the methods used in nine provincial surveys carried out as part of the Canadian Heart Health Initiative.
DESIGN: Population-based cross-sectional surveys, following a core standardized protocol, implemented by provincial departments of health in collaboration with Health and Welfare Canada. Data were obtained through a home interview and a clinic visit. A standard manual of field operations and standardized training procedures were used in all provinces.
SETTING: Nine Canadian provinces during the period 1986 to 1990. PARTICIPANTS: A probability sample of 26,293 men and women aged 18 to 74 years was selected from the health insurance registries in each province. Over 30% of the participants had post-secondary education. About 50% were 18 to 34 years old. OUTCOME MEASURES: Data on sociodemographic characteristics, hypertensive and diabetic status, knowledge and awareness of the causes and consequences of cardiovascular disease and two blood pressure measurements were obtained in a home interview. During a clinic visit, data were collected on height, weight (waist and hip circumferences in four provinces), two blood pressure measures and a blood sample. Total plasma cholesterol, triglycerides and high- and low-density lipoprotein cholesterol were measured in the Lipid Research Laboratory, University of Toronto and St. Michael's Hospital. MAIN
RESULTS: Of the subjects invited to participate in the survey, 78% were interviewed, 69% attended the clinic and 64% provided a fasting specimen (8 hours or more). The response rates were slightly lower for men aged 18 to 34, for women aged 65 to 74 and for those with fewer years of education. Data from the provincial surveys (Ontario will complete the survey in 1992) are being compiled in the Canadian Heart Health Database.
CONCLUSION: The process followed in the implementation of the provincial heart health surveys is a model of how provincial departments of health may carry out epidemiologic investigations in support of their mandate. The approach illustrates how a country-wide database can be built through partnerships among different levels of government. The use of community health nurses was instrumental in the efficient implementation of the surveys and in the realization of the relatively high rates of response attained.

Entities:  

Mesh:

Year:  1992        PMID: 1596846      PMCID: PMC1490359     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  4 in total

1.  Adult physical activity in Canada: findings from the Canada Fitness Survey I.

Authors:  T Stephens; C L Craig; B F Ferris
Journal:  Can J Public Health       Date:  1986 Jul-Aug

2.  Social class differences in ischaemic heart disease in British men.

Authors:  S J Pocock; A G Shaper; D G Cook; A N Phillips; M Walker
Journal:  Lancet       Date:  1987-07-25       Impact factor: 79.321

3.  Relationship of education to major risk factors and death from coronary heart disease, cardiovascular diseases and all causes, Findings of three Chicago epidemiologic studies.

Authors:  K Liu; L B Cedres; J Stamler; A Dyer; R Stamler; S Nanas; D M Berkson; O Paul; M Lepper; H A Lindberg; J Marquardt; E Stevens; J A Schoenberger; R B Shekelle; P Collette; S Shekelle; D Garside
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

4.  Socioeconomic disparities in risk factors for cardiovascular disease.

Authors:  W J Millar; D T Wigle
Journal:  CMAJ       Date:  1986-01-15       Impact factor: 8.262

  4 in total
  35 in total

1.  The impact of a community-based heart disease prevention program in a low-income, inner-city neighborhood.

Authors:  J L O'Loughlin; G Paradis; K Gray-Donald; L Renaud
Journal:  Am J Public Health       Date:  1999-12       Impact factor: 9.308

Review 2.  Creating a Canadian stroke system.

Authors:  E Wilson; G Taylor; S Phillips; P J Stewart; G Dickinson; V R Ramsden; R W Teasell; N Mayo; J Tu; S Elson; B Strauss
Journal:  CMAJ       Date:  2001-06-26       Impact factor: 8.262

3.  Cardiovascular disease: risk factors in older Canadians.

Authors:  D R MacLean
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

Review 4.  The role of global risk assessment in hypertension therapy.

Authors:  S A Grover; Brenda Hemmelgarn; Lawrence Joseph; Alain Milot; Guy Tremblay
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

5.  Body mass index and risk of cardiovascular disease, cancer and all-cause mortality.

Authors:  Peter T Katzmarzyk; Bruce A Reeder; Susan Elliott; Michel R Joffres; Punam Pahwa; Kim D Raine; Susan A Kirkland; Gilles Paradis
Journal:  Can J Public Health       Date:  2012 Mar-Apr

Review 6.  Revisiting Rose: strategies for reducing coronary heart disease.

Authors:  Douglas G Manuel; Jenny Lim; Peter Tanuseputro; Geoffrey M Anderson; David A Alter; Andreas Laupacis; Cameron A Mustard
Journal:  BMJ       Date:  2006-03-18

Review 7.  Genetic determinants of plasma triglycerides.

Authors:  Christopher T Johansen; Sekar Kathiresan; Robert A Hegele
Journal:  J Lipid Res       Date:  2010-11-01       Impact factor: 5.922

8.  Cardiovascular risk factor awareness in a disadvantaged inner-city population--implications for preventive strategies.

Authors:  Brian M Wong; Yelian Garcia; Aiala Barr; Richard H Glazier; Beth L Abramson
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

9.  Coronary heart disease: health knowledge and behaviour.

Authors:  Yazid N Al Hamarneh; Grainne E Crealey; James C McElnay
Journal:  Int J Clin Pharm       Date:  2011-01-13

10.  Preventing cardiovascular disease among Canadians: is the treatment of hypertension or dyslipidemia cost-effective?

Authors:  Steven Grover; Louis Coupal; Ilka Lowensteyn
Journal:  Can J Cardiol       Date:  2008-12       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.